[Drug-induced lung diseases].
Itoh
Yoshinori
Y
Sendo
Toshiaki
T
Oishi
Ryozo
R
D000638:Amiodarone / Q000009:adverse effects*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D004365:Drugs, Chinese Herbal / Q000009:adverse effects; D000077156:Gefitinib; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects; D006801:Humans; D007372:Interferons / Q000009:adverse effects; D007457:Iodine Radioisotopes / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008911:Minocycline / Q000009:adverse effects; D017239:Paclitaxel / Q000009:adverse effects; D011799:Quinazolines / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D018501:Antirheumatic Agents; D003287:Contrast Media; D004365:Drugs, Chinese Herbal; D007457:Iodine Radioisotopes; D011799:Quinazolines; D016179:Granulocyte Colony-Stimulating Factor; D007372:Interferons; D008911:Minocycline; D000638:Amiodarone; D017239:Paclitaxel; D000077156:Gefitinib